QPCT Antikörper
-
- Target Alle QPCT Antikörper anzeigen
- QPCT (Glutaminyl-Peptide Cyclotransferase (QPCT))
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser QPCT Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Aufreinigung
- Affinity purified
- Immunogen
- QPCT antibody was raised using a synthetic peptide corresponding to a region with amino acids SRHLAAKMASTPHPPGARGTSQLHGMDLLVLLDLIGAPNPTFPNFFPNSA
- Top Product
- Discover our top product QPCT Primärantikörper
-
-
- Applikationshinweise
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. - Kommentare
-
QPCT Blocking Peptide, catalog no. 33R-8755, is also available for use as a blocking control in assays to test for specificity of this QPCT antibody
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of QPCT antibody in PBS
- Konzentration
- Lot specific
- Buffer
- PBS
- Handhabung
- Avoid repeated freeze/thaw cycles.
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
- Target
- QPCT (Glutaminyl-Peptide Cyclotransferase (QPCT))
- Andere Bezeichnung
- QPCT (QPCT Produkte)
- Synonyme
- GCT antikoerper, QC antikoerper, sQC antikoerper, QPCT antikoerper, 5730422A13Rik antikoerper, Qpctl1 antikoerper, RGD1562284 antikoerper, qpct antikoerper, glutaminyl-peptide cyclotransferase antikoerper, glutaminyl-peptide cyclotransferase (glutaminyl cyclase) antikoerper, glutaminyl-peptide cyclotransferase L homeolog antikoerper, QPCT antikoerper, Qpct antikoerper, M6_Spy0443 antikoerper, M5005_Spy_0416 antikoerper, M28_Spy0404 antikoerper, CJA_2408 antikoerper, CCNA_02733 antikoerper, Tsp_03182 antikoerper, qpct.L antikoerper
- Hintergrund
- QPCT is responsible for the biosynthesis of pyroglutamyl peptides. QPCT has a bias against acidic and tryptophan residues adjacent to the N-terminal glutaminyl residue and a lack of importance of chain length after the second residue. It also catalyzes N-terminal pyroglutamate formation. In vitro, catalyzes pyroglutamate formation of N-terminally truncated form of APP amyloid-beta peptides [Glu-3]-beta-amyloid.
- Molekulargewicht
- 38 kDa (MW of target protein)
-